ZOMETA CONCENTRATE

Google image searchProduct monograph

Active ingredient

zoledronic acid (zoledronic acid monohydrate), 4 MG/5 ML

DIN: 02248296

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 14-OCT-2004

ATC:

• M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
• M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
• M05BA — Bisphosphonates (ATC, ATC/DDD)
• M05BA08 — ZOLEDRONIC ACID (ATC/DDD)

Reference brand drug: Aclasta

External Links for Zometa Concentrate

Search on Google

• Zometa Concentrate side effects
• Zometa Concentrate dosage
• zoledronic acid side effects
• zoledronic acid dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find zometa concentrate photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.